129 related articles for article (PubMed ID: 30388143)
1. HAVCR1 expression might be a novel prognostic factor for gastric cancer.
Liu L; Song Z; Zhao Y; Li C; Wei H; Ma J; Du Y
PLoS One; 2018; 13(11):e0206423. PubMed ID: 30388143
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
3. Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
Kachko A; Costafreda MI; Zubkova I; Jacques J; Takeda K; Wells F; Kaplan G; Major ME
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321304
[TBL] [Abstract][Full Text] [Related]
4. SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer.
Zhao W; Wang Y; Yue X
Future Oncol; 2018 Sep; 14(21):2139-2148. PubMed ID: 29698084
[TBL] [Abstract][Full Text] [Related]
5. HAVCR1 (CD365) and Its Mouse Ortholog Are Functional Hepatitis A Virus (HAV) Cellular Receptors That Mediate HAV Infection.
Costafreda MI; Kaplan G
J Virol; 2018 May; 92(9):. PubMed ID: 29437974
[TBL] [Abstract][Full Text] [Related]
6. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
7. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
8. CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.
Yang Y; Shi Y; Hou Y; Lu Y; Yang J
Cancer Med; 2018 Mar; 7(3):716-725. PubMed ID: 29473345
[TBL] [Abstract][Full Text] [Related]
9. Significance of aquaporins' expression in the prognosis of gastric cancer.
Thapa S; Chetry M; Huang K; Peng Y; Wang J; Wang J; Zhou Y; Shen Y; Xue Y; Ji K
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29678898
[TBL] [Abstract][Full Text] [Related]
10. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.
Zhang Z; Shen M; Zhou G
Biochem Biophys Res Commun; 2018 Feb; 496(2):482-489. PubMed ID: 29326043
[TBL] [Abstract][Full Text] [Related]
12. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
Zhang J; Dai WJ; Yang XZ
Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions.
Tami C; Silberstein E; Manangeeswaran M; Freeman GJ; Umetsu SE; DeKruyff RH; Umetsu DT; Kaplan GG
J Virol; 2007 Apr; 81(7):3437-46. PubMed ID: 17229699
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation.
Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF
Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097
[TBL] [Abstract][Full Text] [Related]
15. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome.
Xue J; Li Y; Yi J; Jiang H
Gastroenterol Res Pract; 2019; 2019():6746970. PubMed ID: 31885544
[TBL] [Abstract][Full Text] [Related]
16. Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis.
Cheng G; Li M; Wu J; Ji M; Fang C; Shi H; Zhu D; Chen L; Zhao J; Shi L; Xu B; Zheng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9452-7. PubMed ID: 26464703
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.
Zhao J; Mai C; Weng D; Chen C; Zhou Z; Liu Y; Zhou Z; Wang P
Cancer Biomark; 2018; 22(3):375-384. PubMed ID: 29758923
[TBL] [Abstract][Full Text] [Related]
18. Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
Gong Y; Yang J; Wu W; Liu F; Su A; Li Z; Zhu J; Wei T
PLoS One; 2018; 13(5):e0197007. PubMed ID: 29723302
[TBL] [Abstract][Full Text] [Related]
19. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
